Home
About
Overview
Sharing Data
ORCID
Help
History (17)
Coulson, Alan
CRISPR/Cas9 Gene editing of RyR2 in human stem cell-derived cardiomyocytes provides a novel approach in investigating dysfunctional Ca2+ signaling.
Long-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 years.
King, Casey
Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer.
See All 17 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer.
Targeted proteomics identifies liquid-biopsy signatures for extracapsular prostate cancer. Nat Commun. 2016 06 28; 7:11906.
View in:
PubMed
subject areas
Biomarkers
Humans
Liquid Biopsy
Male
Mass Spectrometry
Middle Aged
Prostate
Prostatic Neoplasms
Proteome
Proteomics
authors with profiles
Richard R. Drake